Riesgo de fracturas no vertebrales en mujeres posmenopáusicas en tratamiento antirresortivo

In this large group of postmenopausal women receiving antiresorptive treatment, the 5-year non-vertebral fracture risk, as assessed by the FRACTURE index, was three times higher than that of vertebral fracture.